Latest Sinclair Method Stories
New UCLA psychology research indicates that Asians who are struggling with alcoholism may benefit especially from naltrexone, one of three medications approved by the U.S. Food and Drug Administration for the treatment of alcoholism.
Alcohol-use disorders (AUDs), referring to both alcohol abuse and alcohol dependence, affect nearly 8.5 percent of the American population, are associated with numerous medical, psychiatric, family, legal, and work-related problems, and cost an estimated $185 billion in 1998.
HELSINKI, December 3 /PRNewswire/ -- After two decades of scientifically and medically proven success in their field, Lightlake Therapeutics' experts have been granted ethical approval to begin selecting and gene testing subjects for a trial of a simple, safe and effective treatment for what the World Health Organisation has described as a global epidemic of unhealthy eating and obesity. A Phase II trial for the everyday treatment against obesity and the overeating of unhealthy food, by...
In this trial, a sample of alcohol-dependent patients received naltrexone, acamprosate or placebo for 12 weeks. While there were no differences in outcomes between treatment groups, those who believed they had been taking active medication consumed fewer alcoholic drinks and reported less alcohol dependence and cravings.
German-Swedish study underpins the role that endorphins play in ethanol dependence
FARMINGTON, Conn., Sept. 17 /PRNewswire-USNewswire/ -- Coinciding with National Recovery Month (September), NAABT, Inc.
SAN FRANCISCO and GOLD COAST, Australia, Sept. 6 /PRNewswire/ -- Fresh Start Private, a leader in the treatment of alcohol addiction, today announced the launch of its unique alcoholism recovery program in the United States for the first time.
NEW YORK (Reuters Health) - Providing seniors with personalized information about their drinking and health can effectively reduce their alcohol consumption and other drinking risks, new research found.
- A volcanic mudflow.